BioSpace News Archive

Press Releases

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

May 17, 2026
·
14 min read
Press Releases

Organon to Present New Research on Access and Value at ISPOR 2026

May 17, 2026
·
19 min read
Press Releases

ProKidney Reports First Quarter 2026 Financial Results and Business Highlights

May 17, 2026
·
15 min read
Press Releases

FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment

May 17, 2026
·
10 min read
Press Releases

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

May 17, 2026
·
7 min read
Press Releases

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)

May 17, 2026
·
6 min read
Press Releases

Secretome Therapeutics Announces Participation in Upcoming Summer 2026 Investor Conferences

May 17, 2026
·
2 min read
Press Releases

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

May 17, 2026
·
12 min read
Press Releases

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

May 17, 2026
·
14 min read
Press Releases

Ensysce Biosciences Reports First Quarter 2026 Financial Results

May 17, 2026
·
12 min read